Literature DB >> 24600117

A study to determine the prevalence of pulmonary arterial hypertension in children with Down syndrome and congenital heart disease.

Mukti Sharma1, Sanjeev Khera2, Vishal Sondhi3, Amit Devgan3.   

Abstract

BACKGROUND: Down syndrome (DS) is a common chromosomal abnormality associated with congenital heart disease (CHD). These cardiac abnormalities are known to be associated with pulmonary arterial hypertension (PAH).
METHODS: The aim of this study was to assess the prevalence of PAH in DS children with CHD and to compare it with PAH prevalence in non-syndromic children with CHD. It was a cross-sectional study including all children presenting to Cardiology Department at a tertiary care center between Jan 2007 and Dec 2010.
RESULTS: Thirty-five DS children with CHD were compared with 38 non-syndromic children with CHD. Atrioventricular septal defect (AVSD, 13/35) was the commonest CHD among DS children while isolated VSD (26/38) accounted for maximum cases in non-syndromic CHD. PAH was more prevalent among DS children with CHD (18/42) than among the control group (7/38, p = 0.038). In addition, 14/19 patients with AVSD in the entire cohort developed PAH.
CONCLUSION: DS children with CHD have a higher predisposition to develop PAH, and the likelihood is highest with underlying AVSD.

Entities:  

Keywords:  Atrioventricular septal defects; Congenital heart disease; Down syndrome; Left-to-right shunt; Pulmonary arterial hypertension; Ventricular septal defect

Year:  2013        PMID: 24600117      PMCID: PMC3862969          DOI: 10.1016/j.mjafi.2012.11.013

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN: 0377-1237


  17 in total

1.  Population-based study of congenital heart defects in Down syndrome.

Authors:  S B Freeman; L F Taft; K J Dooley; K Allran; S L Sherman; T J Hassold; M J Khoury; D M Saker
Journal:  Am J Med Genet       Date:  1998-11-16

2.  Mechanisms underlying early development of pulmonary vascular obstructive disease in Down syndrome: An imbalance in biosynthesis of thromboxane A2 and prostacyclin.

Authors:  Hiroyuki Fukushima; Kenjiro Kosaki; Reiko Sato; Tatsuhiko Yagihashi; Ryohei Gatayama; Kazuki Kodo; Takuya Hayashi; Maki Nakazawa; Takatoshi Tsuchihashi; Jun Maeda; Yoshifumi Kojima; Hiroyuki Yamagishi; Takao Takahashi
Journal:  Am J Med Genet A       Date:  2010-08       Impact factor: 2.802

3.  The pulmonary vascular bed in children with Down syndrome.

Authors:  J Chi TPL?Krovetz
Journal:  J Pediatr       Date:  1975-04       Impact factor: 4.406

4.  [Pulmonary hypertension in children with Down's syndrome and congenital heart disease. Is it really more severe?].

Authors:  Clara A Vázquez-Antona; Catalina Lomelí; Alfonso Buendía; Jesús Vargas-Barrón
Journal:  Arch Cardiol Mex       Date:  2006 Jan-Mar

Review 5.  Management of pulmonary hypertension and Down syndrome.

Authors:  P King; R Tulloh
Journal:  Int J Clin Pract Suppl       Date:  2011-12

6.  Atrioventricular canal in Down syndrome. Prevalence of associated cardiac malformations compared with patients without Down syndrome.

Authors:  B Marino; U Vairo; A Corno; S Nava; P Guccione; R Calabrò; C Marcelletti
Journal:  Am J Dis Child       Date:  1990-10

Review 7.  [Heart malformations in children with Down syndrome].

Authors:  Jesús de Rubens Figueroa; Blanca del Pozzo Magaña; José L Pablos Hach; Claudia Calderón Jiménez; Rocío Castrejón Urbina
Journal:  Rev Esp Cardiol       Date:  2003-09       Impact factor: 4.753

8.  Pulmonary hypoplasia in Down's syndrome.

Authors:  T P Cooney; W M Thurlbeck
Journal:  N Engl J Med       Date:  1982-11-04       Impact factor: 91.245

9.  Prevalence of congenital heart defects and persistent pulmonary hypertension of the neonate with Down syndrome.

Authors:  Michel Emile Weijerman; A Marceline van Furth; Maurike D van der Mooren; Miriam M van Weissenbruch; Lukas Rammeloo; Chantal J M Broers; Reinoud J B J Gemke
Journal:  Eur J Pediatr       Date:  2010-04-23       Impact factor: 3.183

10.  Ethnicity, sex, and the incidence of congenital heart defects: a report from the National Down Syndrome Project.

Authors:  Sallie B Freeman; Lora H Bean; Emily G Allen; Stuart W Tinker; Adam E Locke; Charlotte Druschel; Charlotte A Hobbs; Paul A Romitti; Marjorie H Royle; Claudine P Torfs; Kenneth J Dooley; Stephanie L Sherman
Journal:  Genet Med       Date:  2008-03       Impact factor: 8.822

View more
  6 in total

1.  Pulmonary hypertension in patients with 9q34.3 microdeletion-associated Kleefstra syndrome.

Authors:  Volkan Okur; Shannon Nees; Wendy K Chung; Usha Krishnan
Journal:  Am J Med Genet A       Date:  2018-07-31       Impact factor: 2.802

2.  Association Between Sequence Variations in RCAN1 Promoter and the Risk of Sporadic Congenital Heart Disease in a Chinese Population.

Authors:  Xiaoyong Li; Gang Wang; Yong An; Hongbo Li; Yonggang Li; Chun Wu
Journal:  Pediatr Cardiol       Date:  2015-04-12       Impact factor: 1.655

3.  Characterization of SMAD3 Gene Variants for Possible Roles in Ventricular Septal Defects and Other Congenital Heart Diseases.

Authors:  Fei-Feng Li; Jing Zhou; Dan-Dan Zhao; Peng Yan; Xia Li; Ying Han; Xian-Shu Li; Gui-Yu Wang; Kai-Jiang Yu; Shu-Lin Liu
Journal:  PLoS One       Date:  2015-06-25       Impact factor: 3.240

4.  Early Complications After Percutaneous Closure of Atrial Septal Defect in Infants with Procedural Weight Less than 15 kg.

Authors:  Gustaf Tanghöj; Michal Odermarsky; Estelle Naumburg; Petru Liuba
Journal:  Pediatr Cardiol       Date:  2016-11-11       Impact factor: 1.655

Review 5.  Incidence and causes of prolonged mechanical ventilation in children with Down syndrome undergoing cardiac surgery.

Authors:  Bana Agha Nasser; Abdu Rahman Mesned; Tageldein Mohamad; Mohamed S Kabbani
Journal:  J Saudi Heart Assoc       Date:  2018-02-13

6.  Challenges in the Surgical Treatment of Atrioventricular Septal Defect in Children With and Without Down Syndrome in Romania-A Developing Country.

Authors:  Ioana-Cristina Olariu; Anca Popoiu; Andrada-Mara Ardelean; Raluca Isac; Ruxandra Maria Steflea; Tudor Olariu; Adela Chirita-Emandi; Ramona Stroescu; Mihai Gafencu; Gabriela Doros
Journal:  Front Pediatr       Date:  2021-07-07       Impact factor: 3.418

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.